PATENT CLAIM ANALYSIS

Application Number: 16318209
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-09
Patent Classification: ["424", "001890"]

Abstract:
The present invention relates to radiolabeled IDO1 inhibitors or pharmaceutically acceptable salts thereof which are useful for the quantitative imaging of IDO enzymes in mammals.

Claim (Index 6):
A method for monitoring the treatment of a cancer patient who is being treated with an IDO1 inhibitor comprising the steps of:\n (a) administering to the patient the radiolabeled compound of  claim 2 ; (b) obtaining an image of tissues in the patient that express IDO1 enzymes by positron emission tomography (PET); and (c) detecting to what degree said radiolabeled IDO1 inhibitor occupies the binding site of the IDO1 enzyme.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 99.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15505214', '12154445', '15030214', '15316937', '15331446']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.708577842755943
- 35 USC 102 Novelty (BERT): 0.4959464463292315
- Combined Prediction Score: 0.6873147031132719
- Mean Citation Score: 219.596168
- Max Citation Score: 234.1491
- Similarity Product: 166.7971327459395

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test